Lisa Lohrs
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trial.
Journal: Communications medicine
Published: December 16, 2025
Association of psychosis and oral health: case-control study.
Journal: Clinical oral investigations
Published: April 25, 2025
Early Treatment-Resistance in First Episode Psychosis.
Journal: Pharmacopsychiatry
Published: November 15, 2024
Higher blood-brain barrier leakage in schizophrenia-spectrum disorders: A comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls.
Journal: Brain, behavior, and immunity
Published: September 11, 2024
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis.
Journal: Brain, behavior, and immunity
Published: January 28, 2024
The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research.
Journal: Frontiers in psychiatry
Published: March 04, 2023
Blood-brain barrier dysfunction and folate and vitamin B12 levels in first-episode schizophrenia-spectrum psychosis: a retrospective chart review.
Journal: European archives of psychiatry and clinical neuroscience
Published: January 10, 2023
Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders.
Journal: European archives of psychiatry and clinical neuroscience
Published: March 28, 2022
Associations between aerobic fitness, negative symptoms, cognitive deficits and brain structure in schizophrenia-a cross-sectional study.
Journal: Schizophrenia (Heidelberg, Germany)
Published: March 03, 2022
Association between aerobic fitness and the functional connectome in patients with schizophrenia.
Journal: European archives of psychiatry and clinical neuroscience
Published: December 28, 2021
Evaluation of evidence grades in psychiatry and psychotherapy guidelines.
Journal: BMC psychiatry
Published: January 17, 2020
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
Journal: Contemporary clinical trials communications
Published: September 01, 2019
Last Updated: 09/26/2026